Breast cancer screening of mutation carriers in the era of COVID-19 pandemic

Int J Cancer. 2020 Dec 15;147(12):3574-3575. doi: 10.1002/ijc.33160. Epub 2020 Jul 1.

Angela Toss^{1

2}, Matteo Lambertini^{3

4}, Kevin Punie⁵, Giovanni Grandi⁶, Laura Cortesi¹

¹ Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
² Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology and Regenerative Medicine Relevance, University of Modena and Reggio Emilia, Modena, Italy.
³ Department of Medical Oncology, U.O.C Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
⁴ Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy.
⁵ Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.
⁶ Department of Obstetrics, Gynecology and Pediatrics, Obstetrics and Gynecology Unit, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.

No abstract available

Publication types